Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994).
Beeler
J
J
Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Rockville, MD, USA. beeler@a1.cber.fda.gov
Varricchio
F
F
Wise
R
R
D000293:Adolescent; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D002487:Centers for Disease Control and Prevention, U.S. / Q000331:legislation & jurisprudence; D002648:Child; D002675:Child, Preschool; D016208:Databases, Factual; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008458:Measles Vaccine / Q000009:adverse effects*; D011696:Purpura, Thrombocytopenic / Q000209:etiology*; D013921:Thrombocytopenia / Q000209:etiology* / Q000401:mortality; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence; D014611:Vaccination / Q000009:adverse effects / Q000706:statistics & numerical data*
D008458:Measles Vaccine